(Q84582635)
Statements
OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial (English)
S K Aurora
D W Dodick
C C Turkel
R E DeGryse
S D Silberstein
R B Lipton
H C Diener
M F Brin
PREEMPT 1 Chronic Migraine Study Group